UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Handling informative dropout in longitudinal analysis of health-related quality of life: application of three approaches to data from the esophageal cancer clinical trial PRODIGE 5/ACCORD 17

BMC medical research methodology, 2020-09, Vol.20 (1), p.223-223, Article 223

2020

Volltextzugriff (PDF)

Time to deterioration in cancer randomized clinical trials for patient-reported outcomes data: a systematic review

Quality of life research, 2020-04, Vol.29 (4), p.867-878

2020

Volltextzugriff (PDF)

Potency determination of factor VIII and factor IX for new product labelling and postinfusion testing: challenges for caregivers and regulators

Haemophilia : the official journal of the World Federation of Hemophilia, 2015-07, Vol.21 (4), p.543-549

2015

Volltextzugriff (PDF)

TTD and %TUDD: New SAS macro programs to calculate the survival data of the time to deterioration for patient-reported outcomes data in oncology

Computer methods and programs in biomedicine, 2022-02, Vol.214, p.106537-106537, Article 106537

2022

Volltextzugriff (PDF)

REMISSION AFTER CAR T‐CELLS: DO PATIENTS RECOVER A NORMAL LIFE?

Hematological oncology, 2023-06, Vol.41 (S2), p.786-787

2023

Volltextzugriff (PDF)

The Ebola virus ribonucleoprotein complex: A novel VP30–L interaction identified

Virus research, 2009-03, Vol.140 (1), p.8-14

2009

Volltextzugriff (PDF)

Quality of life and response shift effect of diffuse large B‐cell lymphoma French patients included in prospective real‐life REALYSA cohort in the first year after diagnosis

Hematological oncology, 2023-06, Vol.41 (S2), p.428-429

2023

Volltextzugriff (PDF)

Inequality factors in access to early-phase clinical trials in oncology in France: results of the EGALICAN-2 study

ESMO open, 2023-08, Vol.8 (4), p.101610-101610, Article 101610

2023

Volltextzugriff (PDF)

Access to early-phase clinical trials in older patients with cancer in France: the EGALICAN-2 study

ESMO open, 2022-06, Vol.7 (3), p.100468-100468, Article 100468

2022

Volltextzugriff (PDF)

Health-related quality of life profile of newly diagnosed patients with Hodgkin and non-Hodgkin lymphomas: A real-world study including 3922 patients from the French REALYSA cohort

European journal of cancer (1990), 2024-09, Vol.208, p.114210, Article 114210

2024

Volltextzugriff (PDF)

Emotional distress, supportive care needs and age in the prediction of quality of life of cancer patients’ caregivers: A cross-sectional study

European journal of oncology nursing : the official journal of European Oncology Nursing Society, 2023-06, Vol.64, p.102324-102324, Article 102324

2023

Volltextzugriff (PDF)

CO7.4 - Evolution de la qualité de vie des patients atteints d'un lymphome diffus à grandes cellules B après la première ligne de traitement et participant à la cohorte prospective REALYSA

Journal of Epidemiology and Population Health, 2024-05, Vol.72, p.202423, Article 202423

2024

Volltextzugriff (PDF)

Antigen Receptor Signaling to NF- B via CARMA1, BCL10, and MALT1

Cold Spring Harbor perspectives in biology, 2010-09, Vol.2 (9), p.a003004-a003004

2010

Volltextzugriff (PDF)

1680P Feasibility of home-based supervised physical activity (SPA) for metastatic cancer patients receiving oral targeted therapy: The AFSOS-Unicancer QUALIOR randomized phase II study

Annals of oncology, 2021-09, Vol.32, p.S1178-S1178

2021

Volltextzugriff (PDF)

Impact of Open-Label Design on Patient-Reported Outcomes (PROs) Data in Randomized Clinical Trials of Immuno-Oncology (IO) Agents in Patients with Advanced or Metastatic Cancer: A 10-year systematic literature review (SLR)

Annals of oncology, 2019-12, Vol.30, p.xi59-xi60

2019

Volltextzugriff (PDF)

Détérioration de la Qualité de Vie globale des patients atteints d'un cancer œsogastrique à chaque étape du parcours de soin : résultats de l’étude DETAVIE

Revue d'épidémiologie et de santé publique, 2022-05, Vol.70, p.S118-S119

2022

Volltextzugriff (PDF)

Collaborative study for the establishment of the third international standard for nystatin

Pharmeuropa bio & scientific notes, 2010-10, Vol.2010 (2), p.68

2010

Volltextzugriff (PDF)

17th International Conference on Malignant Lymphoma, Palazzo dei Congressi, Lugano, Switzerland, 13 - 17 June, 2023

Hematological oncology, 2023-06, Vol.41 Suppl 2, p.428

2023

Volltextzugriff (PDF)

Impact sur le temps jusqu’à détérioration de la qualité de vie relative à la santé d’une chimiothérapie de première ligne associant ABI-007 et gemcitabine ou LV5FU2 simplifié chez des patients atteints d’un cancer du pancréas métastatique : résultats de l’essai de phase II AFUGEM

Revue d'épidémiologie et de santé publique, 2016-05, Vol.64, p.S142-S143

2016

Volltextzugriff (PDF)

Progress and problems in the replacement of in vivo pharmacopoeial bioassays for hormones

Developments in biologicals, 2002, Vol.111, p.79

2002

Volltextzugriff (PDF)

L’association du bévacizumab au cisplatine-pemetrexed n’altère pas la qualité de vie dans l’étude de phase III IFCT-GFPC-MAPS

Revue des maladies respiratoires, 2019-01, Vol.36, p.A117-A118

2019

Volltextzugriff (PDF)

Hormones: the role of the European Pharmacopoeia

Developments in biological standardization, 1999, Vol.101, p.159

Charton, E

1999

Volltextzugriff (PDF)

Novel pyrogen tests based on the human fever reaction : The report and recommendations of ECVAM workshop 43

Alternatives to laboratory animals, 2001-03, Vol.29 (2), p.99-123

2001

Volltextzugriff (PDF)

Somatropin and its variants: structural characterization and methods of analysis

Pharmeuropa bio, 2004-12, Vol.2004 (1), p.35

2004

Volltextzugriff (PDF)

Elaborating European Pharmacopoeia monographs for biotherapeutic proteins using substances from a single source

Pharmeuropa bio & scientific notes, 2016, Vol.2016, p.129

2016

Volltextzugriff (PDF)

1 – 25 von 155

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(120)
Mit Volltextzugriff
(119)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(63)
Life Sciences & Biomedicine
(47)
Humans
(31)
Animals
(22)
Biological And Medical Sciences
(17)
Physical Sciences
(15)
Life Sciences
(14)
Fundamental And Applied Biological Sciences. Psychology
(12)
Male
(12)
Environmental Sciences & Ecology
(9)
Female
(9)
Ecology
(8)
Environmental Sciences
(8)
Neurosciences
(8)
Neurosciences & Neurology
(8)
Europe
(7)
Mice
(7)
Quality Of Life
(7)
Technology
(7)
Cancer
(6)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Handling informative dropout in longitudinal analysis of health-related quality of life: application of three approaches to data from the esophageal cancer clinical trial PRODIGE 5/ACCORD 17

Time to deterioration in cancer randomized clinical trials for patient-reported outcomes data: a systematic review

Potency determination of factor VIII and factor IX for new product labelling and postinfusion testing: challenges for caregivers and regulators

TTD and %TUDD: New SAS macro programs to calculate the survival data of the time to deterioration for patient-reported outcomes data in oncology

REMISSION AFTER CAR T‐CELLS: DO PATIENTS RECOVER A NORMAL LIFE?

The Ebola virus ribonucleoprotein complex: A novel VP30–L interaction identified

Quality of life and response shift effect of diffuse large B‐cell lymphoma French patients included in prospective real‐life REALYSA cohort in the first year after diagnosis

Inequality factors in access to early-phase clinical trials in oncology in France: results of the EGALICAN-2 study

Access to early-phase clinical trials in older patients with cancer in France: the EGALICAN-2 study

Health-related quality of life profile of newly diagnosed patients with Hodgkin and non-Hodgkin lymphomas: A real-world study including 3922 patients from the French REALYSA cohort

Emotional distress, supportive care needs and age in the prediction of quality of life of cancer patients’ caregivers: A cross-sectional study

CO7.4 - Evolution de la qualité de vie des patients atteints d'un lymphome diffus à grandes cellules B après la première ligne de traitement et participant à la cohorte prospective REALYSA

Antigen Receptor Signaling to NF- B via CARMA1, BCL10, and MALT1

1680P Feasibility of home-based supervised physical activity (SPA) for metastatic cancer patients receiving oral targeted therapy: The AFSOS-Unicancer QUALIOR randomized phase II study

Impact of Open-Label Design on Patient-Reported Outcomes (PROs) Data in Randomized Clinical Trials of Immuno-Oncology (IO) Agents in Patients with Advanced or Metastatic Cancer: A 10-year systematic literature review (SLR)

Détérioration de la Qualité de Vie globale des patients atteints d'un cancer œsogastrique à chaque étape du parcours de soin : résultats de l’étude DETAVIE

Collaborative study for the establishment of the third international standard for nystatin

17th International Conference on Malignant Lymphoma, Palazzo dei Congressi, Lugano, Switzerland, 13 - 17 June, 2023

Impact sur le temps jusqu’à détérioration de la qualité de vie relative à la santé d’une chimiothérapie de première ligne associant ABI-007 et gemcitabine ou LV5FU2 simplifié chez des patients atteints d’un cancer du pancréas métastatique : résultats de l’essai de phase II AFUGEM

Progress and problems in the replacement of in vivo pharmacopoeial bioassays for hormones

L’association du bévacizumab au cisplatine-pemetrexed n’altère pas la qualité de vie dans l’étude de phase III IFCT-GFPC-MAPS

Hormones: the role of the European Pharmacopoeia

Novel pyrogen tests based on the human fever reaction : The report and recommendations of ECVAM workshop 43

Somatropin and its variants: structural characterization and methods of analysis

Elaborating European Pharmacopoeia monographs for biotherapeutic proteins using substances from a single source

Suchergebnisse filtern